Press Release Arialys Therapeutics Publishes Preclinical Data in Nature Communications Supporting ART5803 as a First-in-Class Precision Therapeutic for Anti-NMDA Receptor Autoimmune Neuropsychiatric Disease 17 June 2025
Press Release AXL Launches Venture Studio with $15M to Build 50 AI Companies, Fuelling Canada’s Global Leadership in AI Research-to-Commercialization 17 June 2025
Press Release CORRECTING and REPLACING RAFTR Roofing + Exteriors Appoints George Godfrey as Chief Executive Officer 17 June 2025
Press Release Ferrer Receives FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy (PSP) 17 June 2025
Press Release Xceptor-Commissioned Research: Operational Efficiency Emerges as Key Driver of Digital Transformation in Capital Markets and Data as the Top Priority 17 June 2025
Press Release Mursla Bio Introduces AI Precision Medicine Platform Built on Organ-Specific EV Isolation from Blood 17 June 2025
